<DOC>
	<DOC>NCT02194400</DOC>
	<brief_summary>A one month multi-dose study will evaluate the safety and tolerability of 3 intravenous infusions of RSLV-132 in subjects with inactive to mild SLE.</brief_summary>
	<brief_title>Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus, Systemic</mesh_term>
	<criteria>Stable SLE with no anticipated change in medications for the next 60 days Other biologic drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>RSLV-132</keyword>
	<keyword>Systemic Lupus Erythematosus</keyword>
	<keyword>Lupus</keyword>
	<keyword>SLE</keyword>
	<keyword>Resolve</keyword>
</DOC>